C - Chemistry – Metallurgy – 25 – B
Patent
C - Chemistry, Metallurgy
25
B
204/99.04
C25B 7/00 (2006.01) A61K 35/14 (2006.01) C07K 14/755 (2006.01) A61K 38/00 (2006.01)
Patent
CA 1170618
ABSTRACT OF THE DISCLOSURE Blood Fractionation Improvement The extraction of Factor VIII, the antihaemophilic factor in blood, is difficult due to its instability and the presence of impurities. An initial Factor VIII containing aqueous solution such as blood plasma is purified by subjecting a Factor VIII containing aqueous migrant solution to continuous flow electrophoresis wherein flow takes place in an annular separation chamber and is stabilised by means of an angular velocity gradient; and collecting a separated Factor VIII component. In order to separate the Factor VIII from albumin and firbrinogen, whilst obtaining good recoveries of Factor VIII (e.g. ?60%), the migrant solution is prepared by precipitating Factor VIII from the initial solution using an organic liquid such as ethanol, and removing and redissolving the precipitate in an aqueous medium and adjusting the pH to be within the range of 7.5 to 8.6, preferably 8.3 to 8.6. 12965 M1H
400677
Aitchison Gordon F.
Mattock Patrick
Gowling Lafleur Henderson Llp
United Kingdom Atomic Energy Authority
LandOfFree
Blood fractionation improvement does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Blood fractionation improvement, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Blood fractionation improvement will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1225051